Immunological Evidences for the Presence of Small Late Carboxylterminal Fragment(S) of Human Parathyroid Hormone (PTH) In Circulation in Man
- 1 June 1989
- journal article
- research article
- Published by Taylor & Francis in Journal of Immunoassay
- Vol. 10 (2-3) , 191-205
- https://doi.org/10.1080/01971528908053236
Abstract
Two antisera, C-52 and C-97, raised against bovine (b)PTH(1-84) in guinea pigs, were evaluated with 125I-[tyr53] human (h)PTH(53-84) as tracer and intact hPTH(1-84) and synthetic hPTH(39-84), representative of large carboxylterminal (≪C≫) fragments found in circulation, as standards. In both assays, hPTH(39-84) was 5-6 times more potent than hPTH(1-84) on a molar basis in displacing the tracer. With both antisera, progressive deletion at the aminoterminal end of large ≪C≫ fragments, as in hPTH(53-84) and hPTH(65-84), lead to decreased immunoreactivity, hPTH(69-84) being non-immunoreactive. The mid-carboxylterminal fragments, hPTH(44-68) and hPTH(39-68), did not react in either assay. Each antiserum measured known quantities of pure hPTH(1-84) or hPTH(39-84) standards similarly. Serum PTH values obtained with antiserum C-97 were about 3 times higher in renal failure, 1.75 times higher in normal individuals and those with primary hyperpara-thyroidism, while similar to values measured with antiserum C-52 in individuals with secondary hyperparathyroidism without renal failure or with pseudohypoparathyroidism. When circulating PTH taken from patients with these disorders was fractionated by gel chromatography, both antisera recognized similar peaks of intact hPTH(1-84) and of large ≪C≫ fragments while antiserum C-97 further recognized a peak of smaller ≪C≫ fragments. This explained the different clinical behavior of the latter antiserum. Our findings demonstrate the existence of small late ≪C≫ fragments in circulation. They further suggest an influence of serum calcium and of renal function on the quantity of these fragments.Keywords
This publication has 22 references indexed in Scilit:
- Comparison of Four Different Carboxylterminal Tracers in a Radioimmunoassay Specific to the 68–84 Region of Human Parathyroid HormoneJournal of Immunoassay, 1984
- Characterization of the molecular forms of immunoreactive parathyroid hormone in primary hyperparathyroidism and in hyperparathyroidism due to renal failureScandinavian Journal of Clinical and Laboratory Investigation, 1983
- Detection and Characterization of Small Midregion Parathyroid Hormone Fragment(s) in Normal and Hyperparathyroid Glands and Sera by Immunoextraction and Region-Specific Radioimmunoassays*Journal of Clinical Endocrinology & Metabolism, 1981
- Radioimmunoassay for the Middle Region of Human Parathyroid Hormone: Studies with a Radioiodinated Synthetic Peptide*Journal of Clinical Endocrinology & Metabolism, 1981
- Cytochemical Bioassay of Parathyroid HormoneJournal of Clinical Investigation, 1980
- Influence of immunoheterogeneity of circulating parathyroid hormone on results of radioimmunoassays of serum in manThe American Journal of Medicine, 1974
- Heterogeneity of Parathyroid Hormone. CLINICAL AND PHYSIOLOGIC IMPLICATIONSJournal of Clinical Investigation, 1973
- Activation of Renal Cortical Adenylate Cyclase by Circulating Immunoreactive Parathyroid Hormone FragmentsJournal of Clinical Investigation, 1973
- Etiology of Hyperparathyroidism and Bone Disease during Chronic Hemodialysis. III. EVALUATION OF PARATHYROID SUPPRESSIBILITYJournal of Clinical Investigation, 1973
- Parathyroid Hormone in Human PlasmaJournal of Clinical Investigation, 1972